Altered functional responsiveness of thymocyte subsets from CD3δ-deficient mice to TCR-CD3 engagement

被引:9
作者
Dave, VP
Keefe, R
Berger, MA
Drbal, K
Punt, JA
Wiest, DL
Alarcon, B
Kappes, DJ
机构
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Acad Sci Czech Republ, Inst Mol Genet, CR-14220 Prague 4, Czech Republic
[3] Haverford Coll, Haverford, PA 19041 USA
[4] Univ Autonoma Madrid, CSIC, Ctr Biol Mol, E-28049 Madrid, Spain
关键词
CD3; delta; thymocyte;
D O I
10.1093/intimm/10.10.1481
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD3 delta-deficient (delta degrees) mice are defective in alpha beta T cell development. Here we explore the capacity of TCR-CD3 signaling complexes expressed on delta degrees thymocytes to mediate the following functional outcomes in response to antibody cross-linking: (i) the transition from the CD4(-)CD8(-) to CD4(+)CD8(+) stage, (ii) the transition from the CD4(+)CD8(+) to CD4(+)CD8(-) or CD4(-)CD8(+) stages and (iii) the induction of apoptosis. We provide evidence that CD3 delta epsilon complexes are dispensable for mediating the anti-CD3-mediated CD4(-)CD8(-) to CD4(+)CD8(+) transition. On the other hand, CD3 delta is critical at the CD4(+)CD8(+) stage. We demonstrate that CD4(+)CD8(+) thymocytes from delta degrees mice, unlike delta degrees CD4(-)CD8(-) thymocytes and wild-type CD4(+)CD8(+) thymocytes, require prolonged or consecutive stimuli to elicit functional responses. Depending on the nature of the secondary stimulus, delta degrees thymocytes can be induced to undergo apoptosis or preferential maturation to the CD4(-)CD8(+) stage. Taken together these results indicate that the signaling capacity of the TCR-CD3 complex is noticeably altered in the absence of CD3 delta. The essential role of CD3 delta at the CD4(+)CD8(+) stage of development correlates with the onset of TCR alpha rearrangement, consistent with a critical structural and/or functional relationship between CD3 delta and TCR alpha.
引用
收藏
页码:1481 / 1490
页数:10
相关论文
共 53 条
  • [1] Subunit composition of pre-T cell receptor complexes expressed by primary thymocytes: CD3 delta is physically associated but not functionally required
    Berger, MA
    Dave, V
    Rhodes, MR
    Bosma, GC
    Bosma, MJ
    Kappes, DJ
    Wiest, DL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) : 1461 - 1467
  • [2] CROSS-LINKING OF HUMAN T-CELL RECEPTOR PROTEINS - ASSOCIATION BETWEEN THE T-CELL IDIOTYPE BETA-SUBUNIT AND THE T3 GLYCOPROTEIN HEAVY SUBUNIT
    BRENNER, MB
    TROWBRIDGE, IS
    STROMINGER, JL
    [J]. CELL, 1985, 40 (01) : 183 - 190
  • [3] Surface molecules that drive T cell development in vitro in the absence of thymic epithelium and in the absence of lineage-specific signals
    Cibotti, R
    Punt, JA
    Dash, KS
    Sharrow, SO
    Singer, A
    [J]. IMMUNITY, 1997, 6 (03) : 245 - 255
  • [4] IDENTIFICATION OF A MURINE MONOCLONAL-ANTIBODY SPECIFIC FOR AN ALLOTYPIC DETERMINANT ON MOUSE CD3
    COULIE, PG
    UYTTENHOVE, C
    WAUTERS, P
    MANOLIOS, N
    KLAUSNER, RD
    SAMELSON, LE
    VANSNICK, J
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (07) : 1703 - 1709
  • [5] CD3 delta deficiency arrests development of the alpha beta but not the gamma delta T cell lineage
    Dave, VP
    Cao, ZS
    Browne, C
    Alarcon, B
    FernandezMiguel, G
    Lafaille, J
    delaHera, A
    Tonegawa, S
    Kappes, DJ
    [J]. EMBO JOURNAL, 1997, 16 (06) : 1360 - 1370
  • [6] SPECIFIC ACTIVATION AND TARGETING OF CYTOTOXIC LYMPHOCYTES THROUGH CHIMERIC SINGLE CHAINS CONSISTING OF ANTIBODY-BINDING DOMAINS AND THE GAMMA-SUBUNIT OR ZETA-SUBUNIT OF THE IMMUNOGLOBULIN AND T-CELL RECEPTORS
    ESHHAR, Z
    WAKS, T
    GROSS, G
    SCHINDLER, DG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) : 720 - 724
  • [7] EXLEY M, 1994, J BIOL CHEM, V269, P15140
  • [8] A NOVEL DISULFIDE-LINKED HETERODIMER ON PRE-T-CELLS CONSISTS OF THE T-CELL RECEPTOR-BETA CHAIN AND A 33 KD GLYCOPROTEIN
    GROETTRUP, M
    UNGEWISS, K
    AZOGUI, O
    PALACIOS, R
    OWEN, MJ
    HAYDAY, AC
    VONBOEHMER, H
    [J]. CELL, 1993, 75 (02) : 283 - 294
  • [9] Groves T, 1997, J IMMUNOL, V158, P65
  • [10] HAKS MC, 1998, J EXP MED, V181, P1975